comparemela.com
Home
Live Updates
FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer : comparemela.com
FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer
The designation was granted based on overall survival data from an ongoing randomized phase 2 clinical trial.
Related Keywords
,
Sebastian Kaulitzki ,
Garrett Nichols ,
National Cancer Institute ,
National Library Of Medicine ,
Candel Therapeutics Inc ,
Orphan Drug Designation ,
Candel Therapeutics ,
Chief Medical Officer ,
End Results ,
Paul Peter Tak ,
Chief Executive Officer ,
Orphan Drug ,
Fast Track Designation ,
Therapeutics Receives ,
Drug Designation ,
comparemela.com © 2020. All Rights Reserved.